Figure 4
From: Gene expressions and copy numbers associated with metastatic phenotypes of uterine cervical cancer
Progression free survival analysis. Kaplan Meier plots of progression free survival for 48 cervical cancer patients with high or low gene expression of MRPS23, PDK2, CKS2, and MSN (A), with loss, gain, or no change in gene copy number of MRPS23, PDK2, and MSN (B), and with high or low protein expression of CKS2 and MSN in the tumor cells (C). Number of patients in each group and p-value in log rank test are indicated. The p-values in (A) differ slightly from that in Table 2 because log-rank tests are used in (A), whereas the data in Table 2 are based on Cox regression analysis. Note the concordance in the results based on gene expressions, copy numbers, and protein expressions.